Journal
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Volume 29, Issue 4, Pages 975-979Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/10781552221125763
Keywords
5-Fluorouracil; interferon alpha-2b; ocular surface squamous neoplasia; conjunctival intraepithelial neoplasia; chemotherapy resistance
Categories
Ask authors/readers for more resources
The efficacy and safety of 5-fluorouracil as a second-line treatment for conjunctival intraepithelial neoplasia refractive to interferon alpha-2b were reported. 5-fluorouracil treatment resulted in complete remission of the lesions in both cases without relapse. Fewer side effects were observed compared to other available alternatives.
Purpose To report the efficacy and safety of 5-fluorouracil as the second line of treatment for two cases of conjunctival intraepithelial neoplasia refractive to topical interferon alpha-2b. Case report In the first case, a 77-year-old woman was evaluated because of a fleshy vascularized lesion in the temporal conjunctiva on her right eye with leukoplakia of the corneal epithelium from 10- to 5-o'clock limbus. In the second case, an 81-year-old man, a nodular lesion in the temporal conjunctiva on his RE, with corneal adjacent opalescence, one millimeter in extent, was observed. Both patients were initially treated with excisional surgery, the samples being reported as conjunctival intraepithelial neoplasia with high-grade dysplasia. Co-adjuvant treatment with topical interferon alpha-2b 1 mIU/mL was indicated 4 times/day uninterruptedly. In the first case, there was no response despite 8 months of treatment, while in the second, the corneal lesion progressed in an arboriform pattern after 4 months of topical chemotherapy. Management & outcome In the absence of efficacy, the treatment was then changed to topical 5-fluorouracil (1%), 4 times/day for 7 days with a time-lapse of 21 days off, which constitutes a course. Two and four courses of treatment with 5-fluorouracil 1% were completed in both cases in the absence of important side effects. After the first course, both patients showed complete remission of the lesions. No clinical signs of relapse were noted after 1 year of follow-up. Discussion The treatment with 5-fluorouracil is a good option as the second line of treatment for conjunctival intraepithelial neoplasia who are low-responders to interferon alpha-2b, with fewer side effects than other currently available alternatives.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available